SABCS 2021: PALLAS Fails to Show Benefit of Adding Palbociclib to Adjuvant Endocrine Therapy in Early Breast Cancer
Study author suggests the cyclic treatment regimen may be to blame
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.